Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1442.2000 -40.70 (-2.74%)
NSE Mar 28, 2025 15:31 PM
Volume: 1.5M
 

logo
Cipla Ltd.
31 Oct 2024
1442.20
-2.74%
buy
by BOB Capital Markets Ltd.
Target: 1754 | Upside : 21.6%
BOB Capital Markets Ltd.
Goa plant receiving VAI likely to speed up gAbraxane launch in FY25E. In its 2QFY25 earnings call CIPLA said this would be delayed to H1FY27
 
Number of FII/FPI investors decreased from 1132 to 1077 in Dec 2024 qtr
More from Cipla Ltd.
Recommended
Five Interesting Stocks Today - March 28, 2025
The Baseline | 28 Mar 2025, 05:07PM
Market closes lower, Jio Fin Serv invests Rs 1,000.2 crore in its subsidiary Jio Finance
Trendlyne Marketwatch | 28 Mar 2025, 04:05PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
| 20 May 2022